Will You Need a Booster Shot of the COVID-19 Vaccine?
When the first COVID-19 vaccines from Pfizer-BioNTech and Moderna were authorized by the U.S. Food and Drug Administration in December 2020, most people breathed a sigh of relief since both shots were shown to be between 94% and 95% effective in protecting from COVID-19 symptoms. But public health experts warned that nobody really knew how long the protection would last, since the longest clinical trials in people only went to a few months. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and the chief medical advisor to President Joe Biden, suggested that additional booster ...
Source: TIME: Health - April 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Experimental antiviral for COVID-19 effective in hamster study
(NIH/National Institute of Allergy and Infectious Diseases) The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from NIH scientists. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 16, 2021 Category: Infectious Diseases Source Type: news

Asthma Exacerbations, ED Admissions Decreased During Lockdown
Nonpharmaceutical interventions to reduce COVID - 19 associated with reduction in admissions for COPD, asthma (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 15, 2021 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Journal, Source Type: news

Milk Is Overtaking Nuts as Top Food Allergy Threat Milk Is Overtaking Nuts as Top Food Allergy Threat
Cow's milk is in so many foods that it can be difficult to avoid yet it is the most common food allergy in young children.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 15, 2021 Category: Surgery Tags: Allergy & Clinical Immunology News Source Type: news

The Pandemic Remade Every Corner of Society. Now It ’s the Climate’s Turn
On her third day as the Secretary of Housing and Urban Development, Marcia Fudge phoned the White House. She had taken over an agency with a role to play addressing a range of crises as the lack of affordable housing in U.S. cities has left hundreds of thousands homeless and millions more in financial straits. She connected with Joe Biden’s climate team. Fudge and Gina McCarthy, Biden’s national climate adviser, talked about addressing climate change and the affordable-­housing shortage at the same time. Three weeks later, the Administration announced plans to provide for more than 1 million resilient and e...
Source: TIME: Science - April 15, 2021 Category: Science Authors: Justin Worland Tags: Uncategorized climate change Cover Story feature Magazine TIME 2030 Source Type: news

AHA News: 5 Things to Know This Earth Day About How the Environment Affects Health
Title: AHA News: 5 Things to Know This Earth Day About How the Environment Affects HealthCategory: Health NewsCreated: 4/14/2021 12:00:00 AMLast Editorial Review: 4/15/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - April 15, 2021 Category: Allergy & Immunology Source Type: news

UGA to establish national NIH-funded center to fight flu
(University of Georgia) The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The contract will provide $1 million in first-year funding and is expected to be supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, for seven years and up to approximately $92 million. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 15, 2021 Category: Biology Source Type: news

Nothing Could Make Her Body Stop Itching. Would It Ever End?
It felt like the itch was coming from somehow under her skin. The cause ended up being even deeper. (Source: NYT Health)
Source: NYT Health - April 14, 2021 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Allergies Tests (Medical) Itching Skin Lymph Nodes and Lymphatic System Eczema Source Type: news

NIAID funds new influenza research network
(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks. The program, called the Centers of Excellence for Influenza Research and Response (CEIRR), is expected to be supported for seven years by NIAID contracts to five institutions. Funding for the first year of the contracts will total approximately $24 million. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 14, 2021 Category: Infectious Diseases Source Type: news

Anaphylaxis Case After mRNA Vaccination Traced to Polyethylene Glycol Allergy Anaphylaxis Case After mRNA Vaccination Traced to Polyethylene Glycol Allergy
An undiagnosed polyethylene glycol allergy was at the root of at least one anaphylaxis case associated with an mRNA-based COVID-19 vaccine, a UK report suggests.Reuters Health Information (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 13, 2021 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatmentBasel, 13 April 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic ...
Source: Roche Media News - April 13, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatmentBasel, 13 April 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic ...
Source: Roche Investor Update - April 13, 2021 Category: Pharmaceuticals Source Type: news

NIH experts discuss post-acute COVID-19
(NIH/National Institute of Allergy and Infectious Diseases) Many people who have COVID-19 make a full recovery and return to their baseline state of health; however, some people have symptoms or other sequelae weeks or months after initial SARS-CoV-2 infection. These symptoms were the subject of the " Workshop on Post-acute Sequelae of COVID-19 " hosted on Dec. 2 and 4, 2020, by the National Institute of Allergy and Infectious Diseases (NIAID), in collaboration with other institutes and centers of the NIH. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 13, 2021 Category: Infectious Diseases Source Type: news

NIH trial of anti-CD14 antibody to treat COVID-19 respiratory disease begins
(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes COVID-19, has begun. The Phase 2 trial, called the COVID-19 anti-CD14 Treatment Trial (CaTT), is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2021 Category: International Medicine & Public Health Source Type: news

US begins study of allergic reactions from mRNA coronavirus vaccines, proving covid vaccine long-term safety studies have never been conducted
(Natural News) The U.S. will start a study focusing on the allergic reactions triggered by mRNA Wuhan coronavirus (COVID-19) vaccines. The trial, conducted by the National Institute of Allergy and Infectious Diseases (NIAID), will examine if people with a history of allergies have a higher chance of experiencing reactions beyond the injection site. It will also look... (Source: NaturalNews.com)
Source: NaturalNews.com - April 12, 2021 Category: Consumer Health News Source Type: news

Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%
Basel, 12 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive results from the phase III REGN-COV 2069 trial assessing the ability of the investigational antibody cocktail casirivimab and imdevimab to reduce the risk and burden of COVID-19 infection among household contacts of SARS-CoV-2 infected individuals. The trial, which was jointly run with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), met its primary and key secondary endpoints. It showed that the subcutaneous administration of casirivimab and imdevimab reduced the risk of sym...
Source: Roche Media News - April 12, 2021 Category: Pharmaceuticals Source Type: news

Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%
Basel, 12 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive results from the phase III REGN-COV 2069 trial assessing the ability of the investigational antibody cocktail casirivimab and imdevimab to reduce the risk and burden of COVID-19 infection among household contacts of SARS-CoV-2 infected individuals. The trial, which was jointly run with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), met its primary and key secondary endpoints. It showed that the subcutaneous administration of casirivimab and imdevimab reduced the risk of sym...
Source: Roche Investor Update - April 12, 2021 Category: Pharmaceuticals Source Type: news

Mayo Clinic Minute: How to get spring allergy relief
Springtime brings warmer temperatures and blooming trees. But, for close to 1 in 3 Americans, it also brings annoying seasonal allergies. Dr. Alexei Gonzalez Estrada, a Mayo Clinic allergy specialist, says there are steps you can take to protect yourself. Watch: The Mayo Clinic Minute https://youtu.be/5WigboWy0q8 Journalists: Broadcast-quality video (0:59) is in the downloads at [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 12, 2021 Category: Databases & Libraries Source Type: news

Dietary Advice Poor for Mothers Breastfeeding Infants With Food Allergies
FRIDAY, April 9, 2021 -- Physician recommendations to mothers providing breast milk to children with immunoglobulin (Ig)E-mediated food allergies are inconsistent, according to a study recently published in the Annals of Allergy, Asthma&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2021 Category: Pharmaceuticals Source Type: news

Former Pfizer scientist warns that governments and pharmaceutical companies will continue to deceive and enslave people before killing them off
(Natural News) Dr. Michael Yeadon, Pfizer’s former Vice President and Chief Scientist for Allergy and Respiratory Disease, warns that governments will continue to deceive populations and lie to people about infectious disease diagnosis, transmission and risk. The government’s perpetual deceit and authoritarianism during the covid-19 scandal has been used to control, discriminate, oppress, harass, divide... (Source: NaturalNews.com)
Source: NaturalNews.com - April 9, 2021 Category: Consumer Health News Source Type: news

Dose-Response Analysis Could Improve Peanut Allergy Labeling
THURSDAY, April 8, 2021 -- Estimating the dose-response distribution for peanut allergen in the U.S. population could help improve food labeling guidelines for the management of peanut allergies, according to a study published online March 12 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2021 Category: Pharmaceuticals Source Type: news

NIH experts call for accelerated research to address concurrent HIV and COVID-19 pandemics
(NIH/National Institute of Allergy and Infectious Diseases) The COVID-19 pandemic is affecting people with or at risk for HIV by interfering with HIV treatment and prevention services, and by threatening individual health. An effective response to these dual pandemics requires collaboration to accelerate basic and clinical research, and implementation science to introduce evidence-based strategies into real-world settings. This message comes from a review article co-authored by NIAID director Anthony S. Fauci, M.D., and colleagues published in the Journal of Infectious Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 8, 2021 Category: Infectious Diseases Source Type: news

Former Pfizer VP: 'Your government is lying to you in a way that could lead to your death.'
(Natural News) Dr. Michael Yeadon, Pfizer’s former Vice President and Chief Scientist for Allergy & Respiratory who spent 32 years in the industry leading new medicines research and retired from the pharmaceutical giant with “the most senior research position” in his field, spoke with LifeSiteNews. (Article by Patrick Delaney republished from LifeSiteNews.com) He addressed the “demonstrably false” propaganda... (Source: NaturalNews.com)
Source: NaturalNews.com - April 8, 2021 Category: Consumer Health News Source Type: news

NIDCR's Spring 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR & NIH Stand Against Structural Racism NIDCR Director Rena D’Souza, DDS, MS, PhD, said in a statement that there is no place for structural racism in biomedical research, echoing remarks from NIH Director Francis Collins, MD, PhD, in his announcement of a new NIH ...
Source: NIDCR Science News - April 7, 2021 Category: Dentistry Source Type: news

I Missed My Second COVID-19 Vaccine Appointment. What Happens Now?
Welcome to COVID Questions, TIME’s advice column. We’re trying to make living through the pandemic a little easier, with expert-backed answers to your toughest coronavirus-related dilemmas. While we can’t and don’t offer medical advice—those questions should go to your doctor—we hope this column will help you sort through this stressful and confusing time. Got a question? Write to us at covidquestions@time.com. Today, W.S. in Florida asks: I got my first Pfizer vaccine in January. Is it too late to get the second injection now, more than two months later? What should I do? The second dos...
Source: TIME: Health - April 7, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID Questions COVID-19 Source Type: news

Adrenaclick (epinephrine)
Title: Adrenaclick (epinephrine)Category: MedicationsCreated: 4/7/2021 12:00:00 AMLast Editorial Review: 4/7/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - April 7, 2021 Category: Allergy & Immunology Source Type: news

New insights on cause of anaphylaxis following COVID-19 vaccination
(Wiley) On the first day of the UK campaign for COVID-19 vaccination, there were reports of two cases of anaphylaxis — a severe, potentially life-threatening allergic reaction — within minutes of administration of the Pfizer/BioNTech mRNA vaccine. Subsequently further cases of suspected anaphylaxis to the Pfizer vaccine were reported. A new report published in Clinical& Experimental Allergy reveals that an allergy to the ingredient polyethylene glycol (PEG) is a cause of anaphylaxis to the vaccine. However, this is in the context of millions of doses safely administered. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 7, 2021 Category: Infectious Diseases Source Type: news

Michigan Medicine helps lead national study on possible allergic reaction to COVID vaccine
(Michigan Medicine - University of Michigan) Researchers at Michigan Medicine are helping lead the first national study of how highly allergic people react to mRNA COVID-19 vaccines. The trial, co-led by a U-M immunologist, will cover over 3,000 participants receiving the Pfizer and Moderna vaccines at up to 35 academic allergy research centers across the United States. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 7, 2021 Category: Infectious Diseases Source Type: news

Hayfever prevention: 8 ways to allergy-proof your home
CLEANING is an essential part of managing hay fever symptoms. Here's how to allergy-proof your home. (Source: Daily Express - Health)
Source: Daily Express - Health - April 6, 2021 Category: Consumer Health News Source Type: news

Are you using antihistamines properly?
(McMaster University) People need to rethink what they stock in their home cabinets as allergy medicines, what hospitals keep on formulary, and what policymakers recommend. There are new modern second generation antihistamines that are potent, specific, fast acting and of proven safety which everyone should be using to treat allergic rhinitis and hives. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2021 Category: International Medicine & Public Health Source Type: news

Risk of Quitting Up for Medical Center Employees, Faculty During Pandemic
Lack of child care tied to consideration of leaving the workforce, lessening hours (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 5, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Medicare Spending on Physician Services Down $9.4B During First Half of 2020
Declines seen regardless of service type, setting, or specialty, and state or region (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 5, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Psychiatry, Pul Source Type: news

'Bee' prepared for insect stings
You may not be aware of an allergy until you're stung. Summer's the season for gardening, playing outside, backyard picnics and just enjoying the outdoors. It's also the season of bee and other insect stings. According to the American College of Allergy, Asthma& Immunology, about 5% of the population is allergic to insect stings. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 5, 2021 Category: Databases & Libraries Source Type: news

Mobile Robotic System Perceived as Acceptable for Health Tasks
Survey suggests robotic system perceived as useful; patients report satisfaction with triage interview using mobile robotic system (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 2, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Emergent BioSolutions gets more disappointing news — this time, from the clinic
The study, sponsored by the National Institute of Allergy and Infectious Diseases, tested four antibody therapies including one from the local biotech. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2021 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Today's DIRTY VACCINES and the coinciding spike in blood disorders, allergies and autism
(Natural News) Vaccines are a far cry from the “miracle of modern science” they are touted to be, and now the CDC finds that half of all physicians REFUSE to take routine vaccines themselves due to efficacy and safety concerns. So while the corrupt American medical regime preaches about the necessity of compliance and herd immunity,... (Source: NaturalNews.com)
Source: NaturalNews.com - April 2, 2021 Category: Consumer Health News Source Type: news

Hay fever sufferers warned of ‘pollen bomb’ this Easter weekend - how to manage symptoms
HAY FEVER sufferers have been warned to expect high pollen levels over Easter Weekend with friends and family set to meet outdoors under the newly re-introduced rule of six. Allergy UK has advised the best treatments for managing symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - April 2, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents
New Brunswick, NJ (April 2, 2021) – Johnson & Johnson (the Company) has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. “The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education, mental health, and wellbeing,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. “It is vital that we develop vaccines for eve...
Source: Johnson and Johnson - April 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

If I ’ve Had COVID-19, Do I Still Need Two Doses of Vaccine?
While there are three safe and effective vaccines authorized in the U.S. to protect against COVID-19, there’s still a lot about vaccine immunity that researchers are still trying to figure out. One question has to do with the millions in the U.S. who have been infected with SARS-CoV-2 and recovered. Do they have natural immunity because of their infection, and if so, do they still need to get vaccinated? How much additional protection do the vaccines give them? In a study published April 1 in Nature Medicine, researchers led by a team at Cedars-Sinai Medical Center report that people who recovered from COVID-19 gener...
Source: TIME: Health - April 1, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

SkinMedica(R) Launches Neck Correct Cream for Neck and Décolleté
Revolutionary, Clinically Proven Product Addresses Multi-Factorial Causes & Symptoms of Neck Aging IRVINE, Calif., April 1, 2021 -- (Healthcare Sales & Marketing Network) -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the laun... Biopharmaceuticals, Dermatology, Product Launch AbbVie, SkinMedica, Neck Correct (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2021 Category: Pharmaceuticals Source Type: news

Infant antibiotic exposure can affect future immune responses toward allergies
(Rutgers University) Exposure to antibiotics in utero and infancy can lead to an irreversible loss of regulatory T-cells in the colon -a valuable component of the immune system's response toward allergens in later life - after only six months, a Rutgers researcher found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 1, 2021 Category: International Medicine & Public Health Source Type: news

Community Exposures Tied to SARS - CoV - 2 Seropositivity in HCWs
Workplace factors not linked to seropositivity for health care personnel (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 31, 2021 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Check All Components in Cases of Suspected Shoe Allergy Check All Components in Cases of Suspected Shoe Allergy
Approximately 20% of shoe allergens are not detected with the current screening series, according to a retrospective study of more than 30,000 patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 31, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

How Wearing a Mask Can Reduce Allergy Symptoms
Research shows that wearing masks outdoors can protect against more than Covid-19 for people who suffer from seasonal allergies. (Source: NYT Health)
Source: NYT Health - March 31, 2021 Category: Consumer Health News Authors: Dani Blum Tags: Masks Allergies Protective Clothing and Gear Content Type: Service Pollen Source Type: news

Firdapse (amifampridine)
Title: Firdapse (amifampridine)Category: MedicationsCreated: 3/31/2021 12:00:00 AMLast Editorial Review: 3/31/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - March 31, 2021 Category: Allergy & Immunology Source Type: news

NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins
(NIH/National Institute of Allergy and Infectious Diseases) An investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate's safety and immunogenicity in adult volunteers. The vaccine, known as mRNA-1273.351, was developed by the biotechnology company ModernaTX, Inc., based in Cambridge, Massachusetts. The trial is led and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 31, 2021 Category: International Medicine & Public Health Source Type: news

Revealing meat and fish fraud with a handheld 'MasSpec Pen' in seconds
(American Chemical Society) Meat and fish fraud are global problems, costing consumers billions of dollars every year. On top of that, mislabeling products can cause problems for people with allergies, religious or cultural restrictions. Current methods to detect this fraud, while accurate, are slower than inspectors would like. Now, researchers reporting in ACS' Journal of Agricultural and Food Chemistry have optimized their handheld MasSpec Pen to identify common types of meat and fish within 15 seconds. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 31, 2021 Category: Biology Source Type: news

Covid vaccine: People with history of severe allergies may be 'advised' which jab to have
VACCINE hesitancy is relatively low in Britain compared with its European counterparts but apprehensions do persist. Uncertainty around whether you can have a COVID-19 jab if you've got allergies may put some people off - the team behind the COVID Symptom Study app have busted this myth. (Source: Daily Express - Health)
Source: Daily Express - Health - March 30, 2021 Category: Consumer Health News Source Type: news

Frequency Low for Dual Allergy to Cefazolin, Natural Penicillins
TUESDAY, March 30, 2021 -- Though caution is warranted in patients with confirmed penicillin allergy or a history of severe allergic reactions, most patients with a penicillin allergy history who are undergoing surgical prophylaxis may safely... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 30, 2021 Category: Pharmaceuticals Source Type: news

AstraZeneca vaccine: Is the vaccine safe if you have allergies? What you need to know
VACCINE hesitancy is relatively low in Britain compared with its European counterparts but apprehensions do persist. Uncertainty around whether you can have a COVID-19 jab if you've got allergies may put some people off - the team behind the COVID Symptom Study app have busted this myth. (Source: Daily Express - Health)
Source: Daily Express - Health - March 30, 2021 Category: Consumer Health News Source Type: news